Navigation Links
Obese patients face increased risks for infection and dislocation following revision hip surgery
Date:5/8/2008

ts and 85 percent of the non-obese patients were available for evaluation. In general, the obese patients had moderately lower functional improvements and higher levels of routine hip pain. However, patient satisfaction with the result of their revision THA was gauged to be about the same in both groups.

As its lead author, Dr. Anne Lbbeke, acknowledges, this study is limited by the relatively small number of adverse events resulting in large confidence intervals and restricting the adjustment for baseline differences between obese and non-obese patients to the most important confounding factors. Despite such weaknesses, the findings reinforce revision THA as a technically-challenging intervention, particularly when performed on obese patients.

Surgeons, patients, and referring physicians should be aware of an increased risk in this patient group, Dr. Lbbeke stresses. Further studies are necessary to evaluate whether changes in medical preparation, surgical technique, and implant choice can help reduce the adverse event rate in obese patients undergoing revision THA.


'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. How to manage Chinese obese children with non-alcoholic fatty liver disease?
2. Aspirin-like compounds increase insulin secretion in otherwise healthy obese people
3. Obese women disadvantaged in both breast cancer treatment and diagnosis
4. Obese Women Less Likely to Be Tested for Some Cancers
5. Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise
6. Breast cancer more aggressive among obese women
7. Obese Children Face More Complications During Surgery
8. Overweight and obese men have lower PSA values, even before they get prostate cancer
9. Born to Be Obese?
10. Bone mineral content continues to increase in obese adolescents during weight loss
11. Anti-Inflammatory Drug Improves Glycemia, Lowers Inflammation in Obese, Young Adults
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:CVS Caremark Names New Chief Human Resources Officer 2Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4National Alliance of Wound Care 28R 29 Launches On line Job Resource Center and New Website 60494 1National Alliance of Wound Care 28R 29 Launches On line Job Resource Center and New Website 60494 2ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 1ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 2ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 3ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 4Martel Instruments Expands Its Custom Printer Solutions Business in North America 3B Liz Peirce Named Director of North American Business Development 60491 1Martel Instruments Expands Its Custom Printer Solutions Business in North America 3B Liz Peirce Named Director of North American Business Development 60491 2